Open access
Sep 2026
Combining network pharmacology and experimental validation to explore the therapeutic mechanism of Banxia Xiexin decoction in type 2 diabetes mellitus
BXXD alleviates T2DM-associated metabolic dysregulation by activating the AMPK/SIRT1-mitophagy axis and suppressing inflammation, providing mechanistic evidence supporting further translational investigation of BXXD for T2DM.
Li-Juan Du, Yupeng Chen, Xiu-Gang Zhang et al.
· 3 Biotech · 0 citations